n.krastev

TL2 · Cork

Contributes reviews on supplier material. Based in Cork.

Joined 24 June 2025 · last posted 23h

67 posts, newest first. Showing up to 150.

Why a pen's dose steps are fixed and what that costs you Replied, post #5 · Devices › Pens & autoinjectors · 27 Jul 2026 · 0 likes A pen delivers a fixed or dialled dose from a cartridge and is a metering device rather than simply a covered syringe. That is why dose changes are constrained to…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #45 · Start Here › Welcome · 15 Jul 2026 · 13 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Second pass at: When your prescriber and the evidence disagree Replied, post #45 · Clinical › Prescriber conversations · 4 Jul 2026 · 8 likes I read post #43 twice before replying, because I had assumed the opposite. Prescriber came up in a thread eighteen months ago and was answered well. I cannot find it,…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #40 · Pharmacology › Pharmacokinetics · 3 Jul 2026 · 3 likes Post #38 put the caveat in the right place and I want to underline it. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #21 · Practice › Administration · 23 Jun 2026 · 6 likes Post #19 put the caveat in the right place and I want to underline it. Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests,…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #29 · Analytics › Method validation · 12 Jun 2026 · 0 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
Reading a trial's population section before its results Replied, post #101 · Evidence › Trials · 8 Jun 2026 · 13 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #30 · Evidence › Journal club · 30 May 2026 · 15 likes STEP 1: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
The anatomy of a question that gets answered within an hour Replied, post #54 · Start Here › How to Ask · 23 May 2026 · 0 likes I had written a reply contradicting post #50 and deleted it. Here is what survived. Post the arithmetic you already did. Half the questions here are answered by someone…
Revisiting: Drawing up with one needle and injecting with another Replied, post #55 · Practice › Administration · 6 Apr 2026 · 5 likes Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly injecting one area changes the local tissue over time and eventually changes…
The "under review" status pill and when a moderator applies it Replied, post #11 · Evidence › Preprints · 7 Mar 2026 · 12 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. Noting that the…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #58 · Clinical › Special populations · 1 Mar 2026 · 1 like Pregnancy and breastfeeding are the clearest cases where the answer is that the trials excluded them and the labelling reflects that exclusion. Adding this to the…
Personal import allowances, compared — a second dataset Replied, post #76 · Access › International · 27 Feb 2026 · 20 likes Where I part company with post #73, and it is a narrow parting. The confident answers on Personal import allowances and the well-sourced answers are not the same…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #66 · Practice › Dosing & titration · 18 Feb 2026 · 13 likes Building on post #65 rather than restating it. Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #68 · Compounds › Semaglutide · 17 Feb 2026 · 28 likes The arithmetic in post #67 is right; the assumption feeding it is the part to check. The opalescent appearance in semaglutide solutions is occasionally noted and the…
[2026 update] What a good consultation looks like from the other side Replied, post #16 · Clinical › Prescriber conversations · 14 Feb 2026 · 11 likes Good consultation is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Trifluoroacetate content and its consequences Replied, post #101 · Analytics › Impurities & related substances · 7 Feb 2026 · 0 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #44 · Practice › Interactions · 31 Jan 2026 · 0 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #88 · Clinical › Special populations · 25 Jan 2026 · 5 likes If you are new and reading this thread for the answer to Pregnancy and pregnancy planning: the answer is conditional, the conditions are in the third reply, and the…
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #84 · Clinical › Special populations · 25 Jan 2026 · 0 likes Post #81 is right about the mechanism and I think understates the practical bit. The documentation on older adults is better than this thread and I say that as someone…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #63 · Clinical › Special populations · 24 Jan 2026 · 32 likes Small correction to my own earlier position on Pregnancy and pregnancy planning. I had the units the wrong way round, which changes the conclusion by an order of…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #49 · Clinical › Bloodwork · 11 Jan 2026 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Adding it because I spent an afternoon…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #34 · Devices › Pens & autoinjectors · 23 Dec 2025 · 6 likes The arithmetic in post #33 is right; the assumption feeding it is the part to check. Reusability: some pens are single-use (throw away after one injection). Others can…
Heterogeneity as information rather than as a nuisance Replied, post #23 · Evidence › Meta-analyses · 12 Dec 2025 · 5 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Cross-border purchase rules within the EU Replied, post #50 · Regional › European Union · 6 Dec 2025 · 8 likes Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion. If that…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #22 · Practice › Side effects · 25 Nov 2025 · 0 likes Small methodological point on Injection-site reactions: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Lurking for two months before posting: was that the right call? Replied, post #70 · Start Here › Welcome · 21 Nov 2025 · 1 like Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume. That distinction…
Pen dose counters: what a click does and does not guarantee Replied, post #118 · Devices › Pens & autoinjectors · 20 Nov 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Second pass at: The mass-error checker and its intended scope Replied, post #43 · Data & Tools › Calculators · 20 Oct 2025 · 20 likes Where the mass-error checker reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 2 likes Noted, and thank you for writing it out rather than summarising it.
Waist circumference technique and its repeatability Replied, post #3 · Outcomes › Progress reports · 28 Sep 2025 · 1 like A note on how waist circumference technique gets discussed rather than on waist circumference technique itself: the confident posts get the replies and the careful ones…
Can a home kit substitute for a laboratory report? A careful no Replied, post #6 · Analytics › Home & field testing · 3 Sep 2025 · 12 likes Practical answer on home kit substitute, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #56 · Evidence › Journal club · 29 Aug 2025 · 14 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. I would rather…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #48 · Practice › Reconstitution · 27 Aug 2025 · 25 likes This follows post #47 rather than contradicting it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
Coming back to: What published stability data actually covers, and what it does not Replied, post #104 · Practice › Storage & stability · 4 Aug 2025 · 2 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I have changed my…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #29 · Analytics › Mass spectrometry · 25 Jun 2025 · 4 likes Taking post #28 at face value and following it one step further. An acylated peptide has a mass that reflects the modification, so comparing against the mass of the…
Repeatability versus intermediate precision Replied, post #23 · Analytics › Method validation · 20 Jun 2025 · 14 likes A methods point on repeatability versus intermediate precision rather than a substantive one: if the comparison is not like for like, the difference you are measuring…
Repeatability versus intermediate precision Replied, post #7 · Analytics › Method validation · 17 Jun 2025 · 0 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. I am…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #92 · Compounds › Tirzepatide · 24 May 2025 · 0 likes Small correction to my own earlier position on tirzepatide in type 2 diabetes. I had the units the wrong way round, which changes the conclusion by an order of…
Second pass at: Designing a personal experiment that could change your mind Replied, post #15 · Research Methods › N-of-1 designs · 18 May 2025 · 4 likes Appreciated. The plain phrasing does more work here than a longer post would.
When to stop reading forums, including this one — the long version Replied, post #8 · Wellbeing › Mental health · 3 May 2025 · 18 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #65 · Practice › Reconstitution · 2 May 2025 · 6 likes Worth stating the null on reconstituting a multi-strength kit before we explain it: the observation may be nothing. That possibility deserves a sentence and usually…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #6 · Wellbeing › Mental health · 9 Apr 2025 · 13 likes Answering the question post #2 raises rather than the one it answers. Where medication for mental health is already in place, the interaction question belongs with a…
Validating a method you did not develop — does this still hold? Replied, post #131 · Analytics › Method validation · 18 Mar 2025 · 15 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
Retatrutide dose escalation in the published trials Replied, post #23 · Compounds › Retatrutide · 18 Mar 2025 · 22 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. Why this subcategory is more cautious than elsewhere: retatrutide…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #42 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Not the answer, but…
Cost per milligram, computed honestly across formats — the long version Replied, post #27 · Access › Pricing · 7 Mar 2025 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Insurance tier placement: a compound might be covered but on a higher tier (higher copay).…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #82 · Compounds › Semaglutide · 1 Mar 2025 · 9 likes Published dose-response for semaglutide is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles…
Consistent declarations and why they matter more than clever ones Replied, post #75 · Sourcing › Logistics · 23 Feb 2025 · 6 likes I came in to disagree and I am leaving without a disagreement.
How compounding permissions changed when supply normalised Replied, post #22 · Sourcing › Regulatory · 22 Feb 2025 · 2 likes I read post #18 twice before replying, because I had assumed the opposite. An indication approved for one age range does not extend to another, and paediatric…
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #50 · Practice › Side effects · 15 Feb 2025 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Canadian access and provincial variation Replied, post #59 · Regional › North America · 6 Feb 2025 · 0 likes Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 28 Jan 2025 · 1 like Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Follow-up: What is genuinely unknown about long-term amylin agonism Started this topic · Compounds › Cagrilintide & amylin analogues · 17 Jan 2025 · 0 likes What is genuinely unknown about long-term amylin agonism I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #7 · Evidence › Meta-analyses · 17 Dec 2024 · 20 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
Coming back to: When to suspect the method rather than the sample Replied, post #50 · Analytics › Method validation · 9 Dec 2024 · 27 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. Someone will know this better…
Turnaround times and what they mean for a decision — one year on Replied, post #20 · Sourcing › Independent verification · 9 Dec 2024 · 6 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
Washout with a one-week half-life: the arithmetic Replied, post #96 · Research Methods › N-of-1 designs · 9 Dec 2024 · 4 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. The number is defensible.…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #52 · Evidence › Journal club · 6 Dec 2024 · 0 likes Coming back to post #48, because the follow-up matters more than the original answer. Where the group cannot agree, record the disagreement rather than resolving it by…
[2026 update] How to read a forest plot, properly, from scratch Replied, post #8 · Evidence › Trials · 29 Nov 2024 · 13 likes I had written a reply contradicting post #6 and deleted it. Here is what survived. Absolute and relative effects answer different questions. Write down the event rate…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #41 · Meta › Wiki maintenance · 19 Nov 2024 · 0 likes Taking post #38 at face value and following it one step further. Revision dispute resolved: I have looked for the primary source twice and failed twice. Either it does…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #139 · Clinical › Bloodwork · 24 Oct 2024 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. I would rather post the uncertainty than…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #112 · Access › Shortages · 13 Oct 2024 · 0 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. Reading it again, the caveat matters more…
When a red flag was a misunderstanding, and the retraction Replied, post #14 · Sourcing › Red flags · 9 Sep 2024 · 2 likes Taking post #13 at face value and following it one step further. Practical experience of red flag, offered as one case with the conditions stated, not as a general…
Circumference measurements as a poor man's composition estimate Replied, post #23 · Outcomes › Body composition · 27 Jul 2024 · 1 like Picking up post #22: that is the part I would want checked first. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #14 · Compounds › Retatrutide · 16 Jul 2024 · 32 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
How this community labels and discusses unrefereed work Replied, post #47 · Evidence › Preprints · 28 Jun 2024 · 0 likes Post #44 is right about the mechanism and I think understates the practical bit. If someone has run community labels properly I would rather read that than my own…